65 investors urge drugmakers to tie bonuses to vaccine equity

A group of 65 investment firms are urging drug companies to include global COVID-19 vaccine equity targets as part of their executive compensation policies.

Read the full post at Becker's Hospital Review - Healthcare News
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive